Publicaciones en las que colabora con Javier Martínez Sanz (13)

2024

  1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  2. Transition times across the HIV care continuum in Spain from 2005 to 2022: a longitudinal cohort study

    The Lancet HIV, Vol. 11, Núm. 7, pp. e470-e478

2023

  1. A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease

    Frontiers in Immunology, Vol. 14

  2. CD4/CD8 Ratio During Human Immunodeficiency Virus Treatment: Time for Routine Monitoring?

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 76, Núm. 9, pp. 1688-1696

  3. Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

    EBioMedicine, Vol. 95, pp. 104773

2022

  1. Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2

    Journal of Infection, Vol. 85, Núm. 1, pp. 86-89

  2. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  3. Management of Comorbidities in Treated HIV Infection: A Long Way to Go: HIV, comorbidities and aging

    International Journal of Antimicrobial Agents, Vol. 59, Núm. 1

  4. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

2021

  1. Blood Bacterial Profiles Associated With Human Immunodeficiency Virus Infection and Immune Recovery

    The Journal of infectious diseases, Vol. 223, Núm. 3, pp. 471-481

  2. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  3. Fecal microbiota transplantation in HIV: A pilot placebo-controlled study

    Nature Communications, Vol. 12, Núm. 1

2020

  1. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

    The Lancet HIV, Vol. 7, Núm. 8, pp. e565-e573